Literature DB >> 27406610

Accuracy of pre-contrast imaging in abdominal magnetic resonance imaging of pediatric oncology patients.

Faizah Mohd Zaki1,2, Rahim Moineddin3, Ronald Grant4, Govind B Chavhan5.   

Abstract

BACKGROUND: Safety concerns are increasingly raised regarding the use of gadolinium-based contrast media for MR imaging.
OBJECTIVE: To determine the accuracy of pre-contrast abdominal MR imaging for lesion detection and characterization in pediatric oncology patients.
MATERIALS AND METHODS: We included 120 children (37 boys and 83 girls; mean age 8.94 years) referred by oncology services. Twenty-five had MRI for the first time and 95 were follow-up scans. Two authors independently reviewed pre-contrast MR images to note the following information about the lesions: location, number, solid vs. cystic and likely nature. Pre- and post-contrast imaging reviewed together served as the reference standard.
RESULTS: The overall sensitivity was 88% for the first reader and 90% for the second; specificity was 94% and 91%; positive predictive value was 96% and 94%; negative predictive value was 82% and 84%; accuracy of pre-contrast imaging for lesion detection as compared to the reference standard was 90% for both readers. The difference between mean number of lesions detected on pre-contrast imaging and reference standard was not significant for either reader (reader 1, P = 0.072; reader 2, P = 0.071). There was substantial agreement (kappa values of 0.76 and 0.72 for readers 1 and 2) between pre-contrast imaging and reference standard for determining solid vs. cystic lesion and likely nature of the lesion. The addition of post-contrast imaging increased confidence of both readers significantly (P < 0.0001), but the interobserver agreement for the change in confidence was poor (kappa 0.12).
CONCLUSION: Pre-contrast abdominal MR imaging has high accuracy in lesion detection in pediatric oncology patients and shows substantial agreement with the reference standard for characterization of lesions. Gadolinium-based contrast media administration cannot be completely eliminated but can be avoided in many cases, with the decision made on a case-by-case basis, taking into consideration location and type of tumor.

Entities:  

Keywords:  Abdomen; Children; Contrast medium; Gadolinium; Magnetic resonance imaging; Oncology

Mesh:

Year:  2016        PMID: 27406610     DOI: 10.1007/s00247-016-3664-1

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  19 in total

1.  Progressing Toward a Cohesive Pediatric 18F-FDG PET/MR Protocol: Is Administration of Gadolinium Chelates Necessary?

Authors:  Christopher Klenk; Rakhee Gawande; Vy Thao Tran; Jennifer Trinh Leung; Kevin Chi; Daniel Owen; Sandra Luna-Fineman; Kathleen M Sakamoto; Alex McMillan; Andy Quon; Heike E Daldrup-Link
Journal:  J Nucl Med       Date:  2015-10-15       Impact factor: 10.057

2.  Understanding interobserver agreement: the kappa statistic.

Authors:  Anthony J Viera; Joanne M Garrett
Journal:  Fam Med       Date:  2005-05       Impact factor: 1.756

Review 3.  Imaging pediatric abdominal tumors.

Authors:  Sue C Kaste; M Beth McCarville
Journal:  Semin Roentgenol       Date:  2008-01       Impact factor: 0.800

Review 4.  Is administration of gadolinium-based contrast media to pregnant women and small children justified?

Authors:  Pia C Sundgren; Peter Leander
Journal:  J Magn Reson Imaging       Date:  2011-10       Impact factor: 4.813

5.  Clinical impact of gadolinium in the MRI diagnosis of musculoskeletal infection in children.

Authors:  J Herman Kan; Robert S Young; Chang Yu; Marta Hernanz-Schulman
Journal:  Pediatr Radiol       Date:  2010-02-24

Review 6.  A comprehensive review of the retroperitoneal anatomy, neoplasms, and pattern of disease spread.

Authors:  Sherif Osman; Bruce E Lehnert; Saeed Elojeimy; Irene Cruite; Lorenzo Mannelli; Puneet Bhargava; Mariam Moshiri
Journal:  Curr Probl Diagn Radiol       Date:  2013 Sep-Oct

7.  Diagnosis of osteomyelitis in children: utility of fat-suppressed contrast-enhanced MRI.

Authors:  Lauren W Averill; Andrea Hernandez; Leonardo Gonzalez; Andres H Peña; Diego Jaramillo
Journal:  AJR Am J Roentgenol       Date:  2009-05       Impact factor: 3.959

Review 8.  Pediatric oncology surveillance imaging: two recommendations. Abandon CT scanning, and randomize to imaging or solely clinical follow-up.

Authors:  Kieran McHugh; Derek J Roebuck
Journal:  Pediatr Blood Cancer       Date:  2013-09-21       Impact factor: 3.167

9.  Added utility of gadolinium in the magnetic resonance imaging (MRI) workup of seizures in children younger than 2 years.

Authors:  Myria Petrou; Bradley Foerster; Pavel V Maly; Odd P Eldevik; Steven Leber; Pia C Sundgren
Journal:  J Child Neurol       Date:  2007-02       Impact factor: 1.987

Review 10.  Gadolinium and nephrogenic systemic fibrosis: time to tighten practice.

Authors:  Iosif A Mendichovszky; Stephen D Marks; Clare M Simcock; Oystein E Olsen
Journal:  Pediatr Radiol       Date:  2007-10-18
View more
  2 in total

Review 1.  Use and Safety of Gadolinium Based Contrast Agents in Pediatric MR Imaging.

Authors:  Stephanie Holowka; Manohar Shroff; Govind B Chavhan
Journal:  Indian J Pediatr       Date:  2019-02-22       Impact factor: 1.967

2.  Evaluation of suspected musculoskeletal infection in children over 2 years of age using only fluid-sensitive sequences at MRI.

Authors:  Brian Keegan Markhardt; Kaitlin Woo; Jie C Nguyen
Journal:  Eur Radiol       Date:  2019-03-22       Impact factor: 5.315

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.